Igor Desouza, 27, admitted his guilt in trafficking fentanyl disguised as oxycodone and Xanax, as well as methamphetamine camouflaged as Adderall, both potent substances that pose considerable risks to public health. The U.S. Department of Justice reported that this confession came during Desouza's federal court hearing yesterday, September 1st.
The investigation reached a critical stage in May 2021, when law enforcement conducted a search of Desouza's residence. It was then that they found over 10,000 seemingly harmless pills, which, upon closer examination, turned out to be massive quantities of controlled substances. According to the charging documents, the cache included more than 40 grams of fentanyl pills disguised as oxycodone (some mixed with xylazine) and over two kilograms of methamphetamine pills, some containing MDMA, designed to resemble Adderall or Xanax. An additional search of Desouza's phone revealed images of him handling a firearm and pointing it at orange and blue pills that looked similar to those recovered during the search warrant at his home.
Desouza's illegal enterprise was a result of a coordinated effort with another individual, Matthew Ramos. However, this case remains independent, as Ramos has not yet acknowledged his guilt or been proven guilty beyond reasonable doubt.
Desouza's plea agreement stipulates a 120-month prison sentence, a commitment that speaks to the severity of his crimes.
The sentencing portion of Desouza's case, presided over by U.S. Senior District Court Judge Mark L. Wolf, is scheduled to take place on December 1, 2023. The charges he faces carry minimum sentences, but the maximum punishment could include life in prison, lifelong supervised release, and substantial fines: up to $10 million for the possession with intent to distribute 500 grams or more of methamphetamine and up to $5 million for the possession with intent to distribute 40 grams or more of fentanyl. According to the press release, federal district court judges determine sentencing based upon the U.S. Sentencing Guidelines and other statutory factors.
The investigation was a combined effort involving the Drug Enforcement Administration (DEA) New England Field Division's Boston Tactical Diversion Squad, the Bureau of Alcohol, Tobacco, Firearms & Explosives (ATF) Boston Field Division, the Malden Police Department, and the Middlesex District Attorney's Office.
